|
|
|
Real Estate News Releases
|
(EMAILWIRE.COM, September 30, 2009 ) Windsor, Ontario - Free Hot Penny Stocks, an online financial publication, provides investors timely stock market alerts. If you are interested in penny stocks that are poised to breakout sign up for our free penny stock newsletter. Each day we send out alerts on different hot penny stocks.
Vivakor, Inc. (VIVK) today announced that John Gryga, former executive with General Electric’s Healthcare division and former Director of Operations for RadNet, has joined Vivakor’s Board of Directors. At RadNet, Mr. Gryga was responsible for growing annual revenues from $20 million to over $150 million. Mr. Gryga will steer Vivakor in the commercialization of several of its Electro-Optic devices including its VivaSlices MRI image improvement software and its VivaSight vision-screening digital photo-refractor (“DPR”) product, and other medical devices in development at Vivakor. “John brings a tremendous wealth of experience, contacts and specific commercialization initiatives to the table. All of us at Vivakor welcome John and are excited about the opportunities his presence on the Board will bring the Company,” said Vivakor’s Chairman, Matt Nicosia. The company is traded at a 52 week high on the news at $ 0.55 on light volume.
China Biologic Products, Inc. (CBPO), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that on September 2, 2009, the PRC's State Food and Drug Administration (the "SFDA") renewed SFDA certification of compliance with Good Manufacturing Practices ("GMP") for the production facility of Qianfeng Biological Products Co., Ltd. ("Qianfeng"), China Biologic's indirectly owned subsidiary. "We are pleased that our newly acquired subsidiary's production facility continues to be in compliance with the SFDA's GMP standards, which are in compliance with our commitment to the maintenance of high quality standards in the plasma and blood products industry," said Mr. Chao Ming Zhao, the Company's CEO. "We believe that there are only 32 GMP approved biopharmaceutical companies in China, including our three indirect subsidiaries, which are all currently in compliance with these standards.” In the prior trading session, the stock closed at $7.00. The company opened at $7.50 on the news.
About Freehotpennystocks.com
Freehotpennystocks.com alerts its members on any stocks from penny stocks to NYSE stocks. Our penny stock forum offers free penny stock trading videos, trading software and broker reviews to our members. Our investing forum has discussions on hot penny stocks to long term investments. All the penny stocks that we alert on have above average trading volume, strong news and penny stocks that are moving to the upside quickly. Our penny stock newsletter is great for investors who are starting in the stock market and want a place for information. If you are interest in seeing hot penny stocks and want free penny stock picks come visit freehotpennystocks.com for a free membership. We also track small cap companies and other stocks that may be positioned to break out. Free Hot Penny Stocks is not a registered investment advisor or broker-dealer. Please do your own Due Diligence before investing in any of the stocks mentioned above.
Please click here to read the full disclaimer at http://www.freehotpennystocks.com/disclaimer.html
Resultz Media
Michael Ryan
877-301-9737
staff@freehotpennystocks.com 
|
|
|
|
Real Estate News by Sector
|
|
|
|
|
